RPS6KB1 and breast carcinoma: Furthermore, we are the first to report that phenformin not only activates AMPK but also inactivates mTOR and p70s6k, which act downstream of AMPK, suggesting that the AMPK/mTOR/p70s6k axis may be a major target of phenformin in inducing breast cancer apoptosis.